Product Information

PHENYTEK 200 MG CAPSULE is a brand (anda) product labeled by Mylan Pharmaceuticals Inc., priced at $1.4033 per EA under NDC 00378267001. Its NADAC has been published 378 times since Nov 28, 2013.

FDA first approved this application on Dec 28, 1998.

PHENYTEK 200 MG CAPSULE

extended phenytoin sodium
$1.4033per EA

Strength

200 mg/1

NDC

00378267001

Classification

Brand (ANDA)

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PHENYTOIN SODIUM

Approval Type

Generic (ANDA)

FDA Application

ANDA040298

FDA Approved

12/28/1998

On Market Since

12/10/2001

Pharmacological Classes

Anti-epileptic Agent
Cytochrome P450 1A2 Inducers
Cytochrome P450 2B6 Inducers
Cytochrome P450 2C19 Inducers
Cytochrome P450 2C8 Inducers
Cytochrome P450 2C9 Inducers
Cytochrome P450 2D6 Inducers
Cytochrome P450 3A Inducers
Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for PHENYTEK 200 MG CAPSULE has been published 378 times since Nov 28, 2013, and over the history we have for it it has risen 19.2%. The table below summarizes its recorded NADAC range and movement.

Current price$1.4033 per EA
All-time high$1.4054 (Oct 15, 2025)
All-time low$1.1432 (Jan 22, 2014)
52-week high$1.4054
52-week low$1.3996
Median price$1.3013
Average price$1.3333
Largest weekly change+12.8% (Apr 23, 2014)
Weeks tracked378
Tracking sinceNov 28, 2013

Price History

1W

+0.1%

1M

+0.1%

3M

+0.1%

6M

+0.1%

1Y

-0.0%

3Y

+0.5%

5Y

+0.5%

All

+19.2%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Frequently asked questions

What is the NADAC price of PHENYTEK 200 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for PHENYTEK 200 MG CAPSULE, manufactured by Mylan Pharmaceuticals Inc., is $1.4033 per EA (NDC 00378267001), effective Aug 19, 2026.

How has the price of PHENYTEK 200 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for PHENYTEK 200 MG CAPSULE has risen 19.2%. It has been tracked across 378 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PHENYTEK 200 MG CAPSULE?

Since Nov 28, 2013, the NADAC for PHENYTEK 200 MG CAPSULE has ranged from a low of $1.1432 (Jan 22, 2014) to a high of $1.4054 (Oct 15, 2025), with a median of $1.3013 per EA.

Are there cheaper alternatives to PHENYTEK 200 MG CAPSULE?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as PHENYTEK 200 MG CAPSULE in a comparable dosage form, but none are currently priced below it.

Who manufactures PHENYTEK 200 MG CAPSULE?

PHENYTEK 200 MG CAPSULE (NDC 00378267001) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a brand (anda) product.